Pediatric Antimicrobial Dosage Guidelines

Recommended Dosages

• The American Academy of Pediatrics and other guideline societies recommend a dosage of 20-30 mg/kg as a single daily dose of ornidazole, while ofloxacin should be administered at 7.5 mg/kg every 12 hours (maximum 400 mg/dose) for pediatric patients 1
• For specific infections like plague prophylaxis, the recommended dosage of ofloxacin has been established as an alternative treatment option 1

Age-Based Considerations

• Ofloxacin is generally used in children ≥1 month to ≤17 years, with caution due to potential effects on cartilage development 1
• Fluoroquinolones, including ofloxacin, should be used with caution in young children due to potential effects on cartilage development 1

Safety Considerations

• Fluoroquinolones carry a risk of permanent tooth discoloration and tooth enamel hypoplasia in young children, and should be used only when benefits outweigh risks 1
• Ofloxacin suspension for oral liquid administration is not available in the United States 1

Monitoring

• Regular monitoring for potential adverse effects, particularly with prolonged use of fluoroquinolones, is recommended 1

Ofloxacin Dosage for Pediatric Patients with Tuberculosis

General Dosing Guidelines

• For tuberculosis treatment in children, ofloxacin can be administered at 15-20 mg/kg/day (maximum 1.0 g/day) as a single daily dose or divided into two doses, according to the American Thoracic Society guidelines 2

Special Considerations

• For multidrug-resistant tuberculosis treatment, the current pediatric dosage of 15-20 mg/kg may result in lower drug exposures compared to adults, potentially requiring dosage modifications in certain clinical scenarios, as recommended by the World Health Organization 2

Ofloxacin Pediatric Dosing Guidelines

Systemic (Oral/IV) Dosing

• The American Thoracic Society recommends administering 15-20 mg/kg/day as the standard dosing range for multidrug-resistant tuberculosis (MDR-TB) treatment in children 3

• The American Thoracic Society provides weight-based guidance for ofloxacin dosing in children:

  Weight (kg)	Daily Dose (mg)
  5-6.9	150
  7-9.9	200
  10-13.9	300
  14-19.9	400
  20-29.9	600
  30-39.9	800
  ≥40	1200 (maximum 1.0 g/day) [3]

• For pneumonia caused by susceptible pathogens, the Infectious Diseases Society of America suggests that ofloxacin may be used at doses similar to those of levofloxacin, which are 16-20 mg/kg/day in 2 doses for children 6 months to 5 years old, or 8-10 mg/kg/day once daily for children 5-16 years old (maximum 750 mg daily), although levofloxacin is preferred when a fluoroquinolone is indicated 4, 5

Formulation Availability

• The American Journal of Respiratory and Critical Care Medicine notes that ofloxacin oral suspension is not available in the United States, and tablets must be crushed or split for weight-based dosing in smaller children when treating tuberculosis 3

Ofloxacin Use in Pediatric Infections

Clinical Context for Use

• The American Academy of Pediatrics and the Infectious Diseases Society of America recommend ofloxacin as an alternative therapy for Haemophilus influenzae pneumonia when first-line agents fail, though ciprofloxacin or levofloxacin are preferred fluoroquinolone options 6, 7, 8
• The Centers for Disease Control and Prevention suggest that ofloxacin may be used for plague prophylaxis as an alternative treatment option, but this is not the primary recommendation 6, 7, 8

Preferred Alternatives

• The American Academy of Pediatrics recommends safer alternatives, such as amoxicillin 90 mg/kg/day in 2 doses for community-acquired pneumonia, and azithromycin 10 mg/kg day 1, then 5 mg/kg/day days 2-5 for atypical pneumonia, when a fluoroquinolone is not necessary 6, 7, 8
• The Infectious Diseases Society of America suggests that levofloxacin is generally preferred over ofloxacin, with better-established pediatric dosing, when a fluoroquinolone is necessary 6, 7, 8

Ofloxacin Dosing and Safety in Adolescents

Age-Specific Dosing Framework

• The American Thoracic Society recommends that adult dosing applies starting at age 15 years for ofloxacin administration in adolescents 9
• Long-term use of ofloxacin in adolescents has not been approved due to concerns about effects on bone and cartilage growth, but it may be considered for adolescents with multidrug-resistant tuberculosis when organisms are resistant to both isoniazid and rifampin 9

Treatment Duration Considerations

• The treatment duration for tuberculosis depends on the drug resistance pattern and clinical response, according to the American Thoracic Society 9

Ofloxacin Use in Children

Critical Safety Considerations

• The Centers for Disease Control and Prevention recommends reserving fluoroquinolones, such as ofloxacin, for specific situations in children, including multidrug-resistant tuberculosis and intolerance to first-line agents, due to concerns about safety and efficacy 10
• The American Academy of Pediatrics suggests that fluoroquinolones should not be used for long-term treatment (>several weeks) in children due to potential effects on bone and cartilage growth, with a strength of evidence rated as high 10

Drug Interactions and Monitoring

• The MMWR Recommendations and Reports advise against administering ofloxacin within 2 hours of antacids or medications containing divalent cations, as this can decrease fluoroquinolone absorption, with a strength of evidence rated as moderate 10
• The National Institutes of Health recommend regular monitoring for adverse effects, particularly with prolonged use of ofloxacin, with a strength of evidence rated as low 10

Renal Dosing Adjustments

• The FDA guidelines suggest that ofloxacin dosage should be adjusted if creatinine clearance is <50 mL/minute, as the drug is 80% renally cleared, with a strength of evidence rated as high 10
• The European Medicines Agency notes that supplemental doses of ofloxacin are not necessary after hemodialysis, as the drug is not removed by this process, with a strength of evidence rated as moderate 10

Ofloxacin Dosing in Children for Drug‑Resistant Tuberculosis

Weight‑Based Dose Recommendations

• For children weighing ≥ 40 kg, the guideline recommends 1,200 mg total daily (either 600 mg twice daily or 600 mg once daily). 11
• For children weighing 30–39.9 kg, the recommended total daily dose is 800 mg. 11
• For children weighing 20–29.9 kg, the recommended total daily dose is 600 mg. 11

Weight‑based dosing table

For a child weighing approximately *45 kg, applying the 15–20 mg/kg/day range yields a practical dose of 600–800 mg daily, usually given as 300–400 mg twice daily**. This aligns with the weight‑based table. 11

Practical Tablet Dosing

• When using 100 mg tablets, prescribe 6–8 tablets per day, divided into 2 doses of 3–4 tablets each. 11
• When using 200 mg tablets, prescribe 3–4 tablets per day, divided into 2 doses. 11
• The recommended dose per administration is 7.5 mg/kg every 12 hours (maximum 400 mg per dose), which for a 45 kg child translates to roughly 340 mg per dose and can be rounded to 300–400 mg twice daily. 11

Indications and Use Restrictions

• Ofloxacin in children should be reserved for multidrug‑resistant tuberculosis (MDR‑TB) as the primary indication. 11
• It may also be considered when there is intolerance to first‑line anti‑TB agents or for drug‑resistant infections where the benefits clearly outweigh the risks. (Guideline‑based recommendation) 11

Pharmacokinetic Considerations

• Pediatric dosing results in lower systemic exposure than adult dosing: mean AUC₀₋₂₄ ≈ 66.7 µg·h/mL in children versus ≈ 103 µg·h/mL in adults receiving standard doses. This supports the need for weight‑based dosing rather than adult fixed dosing. 11

Dosing Pitfalls

• Using the adult fixed regimen of 400 mg twice daily without adjusting for body weight can cause over‑dosing in smaller children or under‑dosing in heavier children; always calculate the dose based on the child’s actual weight using the 15–20 mg/kg/day range. 11